Childhood testicular mixed embryonal carcinoma and teratoma
disease diseaseOn this page
Also known as paediatric testicular teratocarcinomapediatric testicular teratocarcinoma
Summary
Childhood testicular mixed embryonal carcinoma and teratoma (MONDO:0003888) is a cancer. A subtype of childhood testicular mixed germ cell cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | childhood testicular mixed embryonal carcinoma and teratoma |
| Mondo ID | MONDO:0003888 |
| DOID | DOID:6474 |
| NCIT | C6539 |
| UMLS | C1333008 |
| MedGen | 234137 |
| GARD | 0023714 |
| Is cancer (heuristic) | yes |
Also known as: childhood testicular mixed embryonal carcinoma and teratoma · paediatric testicular teratocarcinoma · pediatric testicular teratocarcinoma
Disease family
Classification path: cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › reproductive system cancer › male reproductive organ cancer › testicular cancer › malignant testicular germ cell tumor › mixed testicular germ cell cancer › childhood testicular mixed germ cell cancer › childhood testicular mixed embryonal carcinoma and teratoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.